This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-5 Fifth Edition. Available from: https://www.appi.org/diagnostic_and_statistical_manual_of_mental_disorders_dsm-5_fifth_editionAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-5 Fifth Edition. Available from:https://www.appi.org/diagnostic_and_statistical_manual_of_mental_disorders_dsm-5_fifth_editionSearch in Google Scholar
Funayama M, Takata T, Koreki A, Ogino S, Mimura M. Catatonic stupor in schizophrenic disorders and subsequent medical complications and mortality. Psychosom Med 2018;80(4):370–6.FunayamaMTakataTKorekiAOginoSMimuraM. Catatonic stupor in schizophrenic disorders and subsequent medical complications and mortality. Psychosom Med2018;80(4):370–6.10.1097/PSY.0000000000000574Search in Google Scholar
Subramaniyam BA, Muliyala KP, Hari Hara S, Kumar Reddi VS. Prevalence of catatonic signs and symptoms in an acute psychiatric unit from a tertiary psychiatric center in India. Asian J Psychiatry 2019 Aug;44:13–7.SubramaniyamBAMuliyalaKPHari HaraSKumar ReddiVS. Prevalence of catatonic signs and symptoms in an acute psychiatric unit from a tertiary psychiatric center in India. Asian J Psychiatry2019Aug;44:13–7.10.1016/j.ajp.2019.07.003Search in Google Scholar
Cornic F, Consoli A, Tanguy M-L, Bonnot O, Périsse D, Tordjman S, et al. Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res 2009 Sep;113(2-3):233–40.CornicFConsoliATanguyM-LBonnotOPérisseDTordjmanSet al. Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res2009Sep;113(2-3):233–40.10.1016/j.schres.2009.04.021Search in Google Scholar
Kinrys PF, Logan KM. Periodic catatonia in an adolescent. J Am Acad Child Adolesc Psychiatry 2001;40(7):741–2.KinrysPFLoganKM. Periodic catatonia in an adolescent. J Am Acad Child Adolesc Psychiatry2001;40(7):741–2.10.1097/00004583-200107000-00007Search in Google Scholar
Cohen D. Towards a valid nosography and psychopathology of catatonia in children and adolescents. Int Rev Neurobiol 2006;72:131–47.CohenD. Towards a valid nosography and psychopathology of catatonia in children and adolescents. Int Rev Neurobiol2006;72:131–47.10.1016/S0074-7742(05)72008-0Search in Google Scholar
Unal A, Altindag A, Demir B, Aksoy I. The use of Lorazepam and electroconvulsive therapy in the treatment of catatonia: Treatment characteristics and outcomes in 60 patients. J ECT 2017;33(4):290–3.UnalAAltindagADemirBAksoyI. The use of Lorazepam and electroconvulsive therapy in the treatment of catatonia: Treatment characteristics and outcomes in 60 patients. J ECT2017;33(4):290–3.10.1097/YCT.0000000000000433Search in Google Scholar
Sharma CM, Jena S, Sharma D, Agrawal RP. Role of lorazepam challenge test in childhood catatonia. J Pediatr Neurosci 2014;9(3):301–3.SharmaCMJenaSSharmaDAgrawalRP. Role of lorazepam challenge test in childhood catatonia. J Pediatr Neurosci2014;9(3):301–3.10.4103/1817-1745.147611Search in Google Scholar
Roberto AJ, Pinnaka S, Mohan A, Yoon H, Lapidus KAB. Adolescent catatonia successfully treated with Lorazepam and aripiprazole. Case Rep Psychiatry 2014;2014:309517.RobertoAJPinnakaSMohanAYoonHLapidusKAB. Adolescent catatonia successfully treated with Lorazepam and aripiprazole. Case Rep Psychiatry2014;2014:309517.10.1155/2014/309517Search in Google Scholar
Mastain B, Vaiva G, Guerouaou D, Pommery J, Thomas P. [Favourable effect of zolpidem on catatonia]. Rev Neurol (Paris) 1995;151(1):52–6.MastainBVaivaGGuerouaouDPommeryJThomasP. [Favourable effect of zolpidem on catatonia]. Rev Neurol (Paris)1995;151(1):52–6.Search in Google Scholar
Zaw ZF, Bates GD. Replication of zolpidem test for catatonia in an adolescent. Lancet 1997;349(9069):1914.ZawZFBatesGD. Replication of zolpidem test for catatonia in an adolescent. Lancet1997;349(9069):1914.10.1016/S0140-6736(05)63915-3Search in Google Scholar
Peglow S, Prem V, McDaniel W. Treatment of catatonia with zolpidem. J Neuropsychiatry Clin Neurosci 2013;25(3):E13.PeglowSPremVMcDanielW. Treatment of catatonia with zolpidem. J Neuropsychiatry Clin Neurosci2013;25(3):E13.10.1176/appi.neuropsych.1112036724026726Search in Google Scholar
Hawkins JM, Archer KJ, Strakowski SM, Keck PE. Somatic treatment of catatonia. Int J Psychiatry Med 1995;25(4):345–69.HawkinsJMArcherKJStrakowskiSMKeckPE. Somatic treatment of catatonia. Int J Psychiatry Med1995;25(4):345–69.10.2190/X0FF-VU7G-QQP7-L5V7Search in Google Scholar
Moskowitz AK. “Scared stiff”: catatonia as an evolutionary-based fear response. Psychol Rev 2004 Oct;111(4):984–1002.MoskowitzAK. “Scared stiff”: catatonia as an evolutionary-based fear response. Psychol Rev2004Oct;111(4):984–1002.10.1037/0033-295X.111.4.984Search in Google Scholar
Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry 2016;6(4):391–8.RasmussenSAMazurekMFRosebushPI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry2016;6(4):391–8.10.5498/wjp.v6.i4.391Search in Google Scholar
Mittal VA, Bernard JA, Northoff G. What can different motor circuits tell us about psychosis? An RDoC perspective. Schizophr Bull 2017 01;43(5):949–55.MittalVABernardJANorthoffG. What can different motor circuits tell us about psychosis? An RDoC perspective. Schizophr Bull2017 01;43(5):949–55.10.1093/schbul/sbx087Search in Google Scholar
Boy F, Evans CJ, Edden RAE, Singh KD, Husain M, Sumner P. Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol 2010;20(19):1779–85.BoyFEvansCJEddenRAESinghKDHusainMSumnerP. Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol2010;20(19):1779–85.10.1016/j.cub.2010.09.003Search in Google Scholar
Northoff G, Steinke R, Czcervenka C, Krause R, Ulrich S, Danos P, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999;67(4):445–50.NorthoffGSteinkeRCzcervenkaCKrauseRUlrichSDanosPet al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry.1999;67(4):445–50.10.1136/jnnp.67.4.445Search in Google Scholar
Chua HC, Chebib M. GABAA receptors and the diversity in their structure and pharmacology. Adv Pharmacol 2017;79:1–34.ChuaHCChebibM. GABAA receptors and the diversity in their structure and pharmacology. Adv Pharmacol2017;79:1–34.10.1016/bs.apha.2017.03.003Search in Google Scholar
Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, et al. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 2002;451(2):103–10.SannaEBusoneroFTalaniGCartaMMassaFPeisMet al. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol2002;451(2):103–10.10.1016/S0014-2999(02)02191-XSearch in Google Scholar
Thomas P, Rascle C, Mastain B, Maron M, Vaiva G. Test for catatonia with zolpidem. Lancet 1997;349(9053):702.ThomasPRascleCMastainBMaronMVaivaG. Test for catatonia with zolpidem. Lancet1997;349(9053):702.10.1016/S0140-6736(05)60139-0Search in Google Scholar
